Bone quality and vitamin K2 in type 2 diabetes: Review of preclinical and clinical studies

Jun Iwamoto, Yoshihiro Sato, Tsuyoshi Takeda, Hideo Matsumoto

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Type 2 diabetic patients are at high risk of bone fractures even if their bone mineral density is normal or high. This is likely explained by poor bone quality and extraskeletal factors. The present review was conducted to provide an overview of the currently available preclinical and clinical evidence on the effect of vitamin K2 on bone quality in persons with type 2 diabetes. Vitamin K2 stimulates γ-carboxylation of osteocalcin and can increase bone formation through steroid and xenobiotic receptors. Clinical studies of type 2 diabetic patients have shown detrimental collagen cross-links in bone; low serum insulin-like growth factor-I and osteocalcin concentration are associated with an increased risk of fractures. A therapeutic strategy for preventing fractures in type 2 diabetic patients remains to be established. One recent preclinical study showed that vitamin K2 administration in a type 2 diabetic rat model had the following skeletal benefits: increased serum osteocalcin, improved collagen cross-link profiles, and increased bone strength. These new findings suggesting a possible beneficial effect of vitamin K2 supplementation on bone quality in type 2 diabetes warrant further investigation.

Original languageEnglish
Pages (from-to)162-167
Number of pages6
JournalNutrition Reviews
Volume69
Issue number3
DOIs
Publication statusPublished - 2011 Mar

Fingerprint

Vitamin K 2
Type 2 Diabetes Mellitus
Osteocalcin
Bone and Bones
Collagen
Bone Fractures
Serum
Insulin-Like Growth Factor I
Osteogenesis
Bone Density
Clinical Studies

Keywords

  • Bone fracture
  • Bone mineral density
  • Bone quality
  • Type 2 diabetes
  • Vitamin K

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Bone quality and vitamin K2 in type 2 diabetes : Review of preclinical and clinical studies. / Iwamoto, Jun; Sato, Yoshihiro; Takeda, Tsuyoshi; Matsumoto, Hideo.

In: Nutrition Reviews, Vol. 69, No. 3, 03.2011, p. 162-167.

Research output: Contribution to journalArticle

Iwamoto, Jun ; Sato, Yoshihiro ; Takeda, Tsuyoshi ; Matsumoto, Hideo. / Bone quality and vitamin K2 in type 2 diabetes : Review of preclinical and clinical studies. In: Nutrition Reviews. 2011 ; Vol. 69, No. 3. pp. 162-167.
@article{ba5eb1b0251740f99cb9030319e8776e,
title = "Bone quality and vitamin K2 in type 2 diabetes: Review of preclinical and clinical studies",
abstract = "Type 2 diabetic patients are at high risk of bone fractures even if their bone mineral density is normal or high. This is likely explained by poor bone quality and extraskeletal factors. The present review was conducted to provide an overview of the currently available preclinical and clinical evidence on the effect of vitamin K2 on bone quality in persons with type 2 diabetes. Vitamin K2 stimulates γ-carboxylation of osteocalcin and can increase bone formation through steroid and xenobiotic receptors. Clinical studies of type 2 diabetic patients have shown detrimental collagen cross-links in bone; low serum insulin-like growth factor-I and osteocalcin concentration are associated with an increased risk of fractures. A therapeutic strategy for preventing fractures in type 2 diabetic patients remains to be established. One recent preclinical study showed that vitamin K2 administration in a type 2 diabetic rat model had the following skeletal benefits: increased serum osteocalcin, improved collagen cross-link profiles, and increased bone strength. These new findings suggesting a possible beneficial effect of vitamin K2 supplementation on bone quality in type 2 diabetes warrant further investigation.",
keywords = "Bone fracture, Bone mineral density, Bone quality, Type 2 diabetes, Vitamin K",
author = "Jun Iwamoto and Yoshihiro Sato and Tsuyoshi Takeda and Hideo Matsumoto",
year = "2011",
month = "3",
doi = "10.1111/j.1753-4887.2011.00380.x",
language = "English",
volume = "69",
pages = "162--167",
journal = "Nutrition Reviews",
issn = "0029-6643",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Bone quality and vitamin K2 in type 2 diabetes

T2 - Review of preclinical and clinical studies

AU - Iwamoto, Jun

AU - Sato, Yoshihiro

AU - Takeda, Tsuyoshi

AU - Matsumoto, Hideo

PY - 2011/3

Y1 - 2011/3

N2 - Type 2 diabetic patients are at high risk of bone fractures even if their bone mineral density is normal or high. This is likely explained by poor bone quality and extraskeletal factors. The present review was conducted to provide an overview of the currently available preclinical and clinical evidence on the effect of vitamin K2 on bone quality in persons with type 2 diabetes. Vitamin K2 stimulates γ-carboxylation of osteocalcin and can increase bone formation through steroid and xenobiotic receptors. Clinical studies of type 2 diabetic patients have shown detrimental collagen cross-links in bone; low serum insulin-like growth factor-I and osteocalcin concentration are associated with an increased risk of fractures. A therapeutic strategy for preventing fractures in type 2 diabetic patients remains to be established. One recent preclinical study showed that vitamin K2 administration in a type 2 diabetic rat model had the following skeletal benefits: increased serum osteocalcin, improved collagen cross-link profiles, and increased bone strength. These new findings suggesting a possible beneficial effect of vitamin K2 supplementation on bone quality in type 2 diabetes warrant further investigation.

AB - Type 2 diabetic patients are at high risk of bone fractures even if their bone mineral density is normal or high. This is likely explained by poor bone quality and extraskeletal factors. The present review was conducted to provide an overview of the currently available preclinical and clinical evidence on the effect of vitamin K2 on bone quality in persons with type 2 diabetes. Vitamin K2 stimulates γ-carboxylation of osteocalcin and can increase bone formation through steroid and xenobiotic receptors. Clinical studies of type 2 diabetic patients have shown detrimental collagen cross-links in bone; low serum insulin-like growth factor-I and osteocalcin concentration are associated with an increased risk of fractures. A therapeutic strategy for preventing fractures in type 2 diabetic patients remains to be established. One recent preclinical study showed that vitamin K2 administration in a type 2 diabetic rat model had the following skeletal benefits: increased serum osteocalcin, improved collagen cross-link profiles, and increased bone strength. These new findings suggesting a possible beneficial effect of vitamin K2 supplementation on bone quality in type 2 diabetes warrant further investigation.

KW - Bone fracture

KW - Bone mineral density

KW - Bone quality

KW - Type 2 diabetes

KW - Vitamin K

UR - http://www.scopus.com/inward/record.url?scp=79951883835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951883835&partnerID=8YFLogxK

U2 - 10.1111/j.1753-4887.2011.00380.x

DO - 10.1111/j.1753-4887.2011.00380.x

M3 - Article

C2 - 21348880

AN - SCOPUS:79951883835

VL - 69

SP - 162

EP - 167

JO - Nutrition Reviews

JF - Nutrition Reviews

SN - 0029-6643

IS - 3

ER -